Wednesday, February 6, 2013

• Oxygen Biotherapeutics and the U.S. Army Institute of Surgical Research Sign a Cooperative Research and Development Agreement to Study the Effects of Oxycyte® on Ex Vivo Platelet FunctionBusiness Wire (Wed, Feb 6)

Wednesday, January 30, 2013

• Oxygen Biotherapeutics Announces It Will Present at the 15th Annual BIO CEO & Investor Conference on February 11Business Wire (Wed, Jan 30)

Tuesday, January 8, 2013

• Oxygen Biotherapeutics Announces It Will Present at OneMedForum Conference on Wednesday January 9thBusiness Wire (Tue, Jan 8)

Monday, December 17, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online (Mon, Dec 17)
• Oxygen Biotherapeutics Reports Second Quarter FY2013 Financial ResultsBusiness Wire (Mon, Dec 17)

Friday, December 14, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Dec 14)
• New Stock Coverage: Microsoft Still Has Major Issuesat Minyanville (Fri, Dec 14)

Thursday, December 6, 2012

• Oxygen Biotherapeutics Announces Second Quarter FY2013 Financial Results Conference Call and WebcastBusiness Wire (Thu, Dec 6)

Tuesday, November 20, 2012

• PPD to test Oxygen Biotherapeutics drugat bizjournals.com (Tue, Nov 20)
• Oxygen Biotherapeutics Engages PPD to Execute Remainder of Phase IIb Clinical Trial to Evaluate the Safety and Tolerability of Oxycyte® in Severe Traumatic Brain InjuryBusiness Wire (Tue, Nov 20)

Friday, October 26, 2012

• Oxygen trying to get proposed drug back on trackat bizjournals.com (Fri, Oct 26)

Thursday, October 25, 2012

• Oxygen trying to get proposed drug back on trackat bizjournals.com (Thu, Oct 25)

Monday, October 8, 2012

• Delisting danger deja vu for Oxygen Biotherapeuticsat bizjournals.com (Mon, Oct 8)

Friday, October 5, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule oEDGAR Online (Fri, Oct 5)

Wednesday, October 3, 2012

• Oxygen Biotherapeutics signs R&D agreement with U.S. Navyat theflyonthewall.com (Wed, Oct 3)

Friday, September 21, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule oEDGAR Online (Fri, Sep 21)

Thursday, September 20, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online (Thu, Sep 20)

Wednesday, September 19, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Wed, Sep 19)

Friday, September 7, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online (Fri, Sep 7)

Tuesday, August 28, 2012

• Oxygen Biotherapeutics relocating R&D function to North Carolinaat theflyonthewall.com (Tue, Aug 28)
• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Aug 28)

Wednesday, July 25, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 10-K, Annual ReportEDGAR Online (Wed, Jul 25)
• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online (Wed, Jul 25)

Friday, June 15, 2012

• OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, FinancialEDGAR Online (Fri, Jun 15)

Add OXBT News to My Yahoo!